Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

GSK plans first-in-human study of GSK-2330811 for inflammatory and fibrotic diseases

March 18, 2015

Samsung Bioepis submits MAA to EMA for Remicade biosimilar

March 16, 2015

Corbus Pharmaceuticals receives IND clearance from FDA to begin phase II trials of Resunab

March 13, 2015

Medtronic invests in Flex Pharma IPO

March 6, 2015

Cadila Healthcare patents new JAK inhibitors

March 3, 2015

Ampio reports results from phase II portion of STRUT study of Ampion in OA

Feb. 27, 2015

Eli Lilly and Incyte report phase III data for baricitinib in rheumatoid arthritis

Feb. 24, 2015

Cytori initiates phase II cell therapy trial for knee osteoarthritis

Feb. 19, 2015

Novartis patent divulges PI3Kdelta/gamma inhibitors

Feb. 18, 2015

First clinical study of ONS-3010 meets primary endpoints

Feb. 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...